Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells
2023 · Cancer Cell International · 16 citations
https://doi.org/10.1186/s12935-023-02957-z